Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia

Acute myeloid leukemia carries a dismal prognosis in older patients. The objective of this study was to investigate the safety and efficacy of decitabine combined with the CXCR4 antagonist plerixafor in newly diagnosed older patients with acute myeloid leukemia and to evaluate the effects of plerixa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Roboz, Gail J., Ritchie, Ellen K., Dault, Yulia, Lam, Linda, Marshall, Danielle C., Cruz, Nicole M., Hsu, Hsiao-Ting C., Hassane, Duane C., Christos, Paul J., Ippoliti, Cindy, Scandura, Joseph M., Guzman, Monica L.
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6068018/
https://ncbi.nlm.nih.gov/pubmed/29724902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.183418
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars